These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33754222)

  • 1. Rebuttal letter on "Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature".
    Rocha FAC; Deodhar A
    Clin Rheumatol; 2021 May; 40(5):2107-2108. PubMed ID: 33754222
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature".
    Maatallah K; Ben Nessib D; Hamdi W
    Clin Rheumatol; 2021 May; 40(5):2109-2110. PubMed ID: 33754223
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature.
    Rocha FAC; Pinto ACMD; Lopes JR; Deodhar A
    Clin Rheumatol; 2021 May; 40(5):1881-1887. PubMed ID: 33230684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept for Ankylosing Spondylitis With Coexisting Demyelinating Myelitis.
    Ye C; Geng Z; Li S; Yu F
    Am J Ther; 2019; 26(5):e629-e631. PubMed ID: 30199382
    [No Abstract]   [Full Text] [Related]  

  • 5. Correction to: Rebuttal letter on "Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature".
    Rocha FAC; Deodhar A
    Clin Rheumatol; 2021 Jul; 40(7):3025. PubMed ID: 33948769
    [No Abstract]   [Full Text] [Related]  

  • 6. Polychondritis in a Patient With Ankylosing Spondylitis on an Anti-TNF-α Biosimilar Agent.
    Duro T; Li S; Jose D; Khawar T
    J Clin Rheumatol; 2021 Dec; 27(8S):S656. PubMed ID: 35073638
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscular sarcoidosis under anti-TNF treatment in ankylosing spondylitis.
    Wendling D; Nueffer JP
    Joint Bone Spine; 2018 Dec; 85(6):769. PubMed ID: 29787812
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance of Low Disease Activity following Tumor Necrosis Factor Inhibitor Dose Tapering in Ankylosing Spondylitis.
    Steel L; Gaffney K
    J Rheumatol; 2017 Aug; 44(8):1292. PubMed ID: 28765347
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of etanercept on iritis in patients with ankylosing spondylitis.
    Rosenbaum JT
    Arthritis Rheum; 2004 Nov; 50(11):3736-7. PubMed ID: 15529379
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of essential thrombocythemia and ankylosing spondylitis treated with a combination of anagrelide, disease-modifying antirheumatic drugs, and etanercept.
    Zeremski V; Savić A; Ilić T; Milosević I; Maksimović M; Vucković B
    Srp Arh Celok Lek; 2016; 144(1-2):81-4. PubMed ID: 27276864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scrotal pain of a patient with ankylosing spondylitis successfully treated with TNF-alpha inhibitor: a case report.
    Suzuki H; Tsujimoto T; Ota M; Hasegawa Y; Oha F; Shimamura Y; Tanaka M; Hashimoto T; Iwasaki N; Kanayama M
    J Orthop Sci; 2024 Jan; 29(1):402-404. PubMed ID: 35690543
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiographic Evidence of Hip Joint Recovery in Patients with Ankylosing Spondylitis after Treatment with Anti-tumor Necrosis Factor Agents: A Case Series.
    Song R; Chung SW; Lee SH
    J Rheumatol; 2017 Nov; 44(11):1759-1760. PubMed ID: 29093078
    [No Abstract]   [Full Text] [Related]  

  • 13. Palmoplantar pustulosis secondary to anti-tumor necrosis factor therapy in a patient with ankylosing spondylitis.
    Bae JM; Eun SH; Kim KJ
    Korean J Intern Med; 2020 Jan; 35(1):254-255. PubMed ID: 31623028
    [No Abstract]   [Full Text] [Related]  

  • 14. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study.
    Batteux B; Devauchelle A; Boyard PL; Sejourné A; Fardellone P; Goëb V
    Joint Bone Spine; 2016 Oct; 83(5):607-9. PubMed ID: 26919803
    [No Abstract]   [Full Text] [Related]  

  • 16. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
    van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
    J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study.
    Chen YY
    Medicine (Baltimore); 2017 Mar; 96(9):e5993. PubMed ID: 28248857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.